Skip to main content
Top
Published in: Osteoporosis International 6/2007

01-06-2007 | Original Article

Osteoclasts prefer aged bone

Authors: K. Henriksen, D. J. Leeming, I. Byrjalsen, R. H. Nielsen, M. G. Sorensen, M. H. Dziegiel, T. John Martin, C. Christiansen, P. Qvist, M. A. Karsdal

Published in: Osteoporosis International | Issue 6/2007

Login to get access

Abstract

Summary

We investigated whether the age of the bones endogenously exerts control over the bone resorption ability of the osteoclasts, and found that osteoclasts preferentially develop and resorb bone on aged bone. These findings indicate that the bone matrix itself plays a role in targeted remodeling of aged bones.

Introduction

Osteoclasts resorb aging bone in order to repair damage and maintain the quality of bone. The mechanism behind the targeting of aged bone for remodeling is not clear. We investigated whether bones endogenously possess the ability to control osteoclastic resorption.

Methods

To biochemically distinguish aged and young bones; we measured the ratio between the age-isomerized βCTX fragment and the non-isomerized αCTX fragment. By measurement of TRACP activity, CTX release, number of TRACP positive cells and pit area/pit number, we evaluated osteoclastogenesis as well as osteoclast resorption on aged and young bones.

Results

We found that the αCTX / βCTX ratio is 3:1 in young compared to aged bones, and we found that both α and βCTX are released by osteoclasts during resorption. Osteoclastogenesis was augmented on aged compared to young bones, and the difference was enhanced under low serum conditions. We found that mature osteoclasts resorb more on aged than on young bone, despite unchanged adhesion and morphology.

Conclusions

These data indicate that the age of the bone plays an important role in controlling osteoclast-mediated resorption, with significantly higher levels of osteoclast differentiation and resorption on aged bones when compared to young bones.
Literature
1.
go back to reference Frost HM (1969) Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 3:211–237PubMedCrossRef Frost HM (1969) Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 3:211–237PubMedCrossRef
2.
go back to reference Parfitt AM (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5–7PubMedCrossRef Parfitt AM (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5–7PubMedCrossRef
3.
go back to reference Han ZH, Palnitkar S, Rao DS et al (1997) Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 12:498–508PubMedCrossRef Han ZH, Palnitkar S, Rao DS et al (1997) Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 12:498–508PubMedCrossRef
4.
go back to reference Burr DB, Martin RB (1993) Calculating the probability that microcracks initiate resorption spaces. J Biomech 26:613–616PubMedCrossRef Burr DB, Martin RB (1993) Calculating the probability that microcracks initiate resorption spaces. J Biomech 26:613–616PubMedCrossRef
5.
go back to reference Noble B (2003) Bone microdamage and cell apoptosis. Eur Cell Mater 6:46–55PubMed Noble B (2003) Bone microdamage and cell apoptosis. Eur Cell Mater 6:46–55PubMed
8.
9.
go back to reference Fledelius C, Johnsen AH, Cloos PA et al (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region. J Biol Chem 272:9755–9763PubMedCrossRef Fledelius C, Johnsen AH, Cloos PA et al (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region. J Biol Chem 272:9755–9763PubMedCrossRef
10.
go back to reference Cloos PA, Lyubimova N, Solberg H et al (2004) An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin Lab 50:279–289PubMed Cloos PA, Lyubimova N, Solberg H et al (2004) An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin Lab 50:279–289PubMed
11.
go back to reference Cloos PA, Fledelius C (2000) Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 345(Pt 3):473–480PubMedCrossRef Cloos PA, Fledelius C (2000) Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 345(Pt 3):473–480PubMedCrossRef
12.
go back to reference Currey JD, Brear K, Zioupos P (1996) The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech 29:257–260PubMedCrossRef Currey JD, Brear K, Zioupos P (1996) The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech 29:257–260PubMedCrossRef
13.
go back to reference Dickson IR, Bagga MK (1985) Changes with age in the non-collagenous proteins of human bone. Connect. Tissue Res 14:77–85PubMed Dickson IR, Bagga MK (1985) Changes with age in the non-collagenous proteins of human bone. Connect. Tissue Res 14:77–85PubMed
14.
go back to reference Triffitt JT (1976) Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein. Calcif Tissue Res 22:27–33PubMed Triffitt JT (1976) Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein. Calcif Tissue Res 22:27–33PubMed
15.
go back to reference Fedarko NS, Vetter UK, Weinstein S et al (1992) Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol 151:215–227PubMedCrossRef Fedarko NS, Vetter UK, Weinstein S et al (1992) Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol 151:215–227PubMedCrossRef
16.
go back to reference Perkins SL, Gibbons R, Kling S et al (1994) Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone 15:65–72PubMedCrossRef Perkins SL, Gibbons R, Kling S et al (1994) Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone 15:65–72PubMedCrossRef
17.
go back to reference Noble BS, Stevens H, Loveridge N et al (1997) Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20:273–282PubMedCrossRef Noble BS, Stevens H, Loveridge N et al (1997) Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20:273–282PubMedCrossRef
18.
go back to reference Bonewald LF (2002) Osteocytes: a proposed multifunctional bone cell. J Musculoskelet Neuronal Interact 2:239–241PubMed Bonewald LF (2002) Osteocytes: a proposed multifunctional bone cell. J Musculoskelet Neuronal Interact 2:239–241PubMed
19.
go back to reference Noble BS, Peet N, Stevens HY et al (2003) Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284:C934–C943PubMed Noble BS, Peet N, Stevens HY et al (2003) Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284:C934–C943PubMed
20.
go back to reference Cao J, Venton L, Sakata T et al (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270–277PubMedCrossRef Cao J, Venton L, Sakata T et al (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270–277PubMedCrossRef
21.
go back to reference Ueland T, Brixen K, Mosekilde L et al (2003) Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab 88:1014–1018; 2003PubMedCrossRef Ueland T, Brixen K, Mosekilde L et al (2003) Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. J Clin Endocrinol Metab 88:1014–1018; 2003PubMedCrossRef
22.
go back to reference Karsdal MA, Hjorth P, Henriksen K et al (2003) TGF-beta controls human osteoclastogenesis through the p38 MAP kinase and regulation of RANK expression. J Biol Chem 278:44975–44987PubMedCrossRef Karsdal MA, Hjorth P, Henriksen K et al (2003) TGF-beta controls human osteoclastogenesis through the p38 MAP kinase and regulation of RANK expression. J Biol Chem 278:44975–44987PubMedCrossRef
23.
go back to reference Henriksen K, Gram J, Schaller S et al (2004) Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537–1545PubMed Henriksen K, Gram J, Schaller S et al (2004) Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537–1545PubMed
24.
go back to reference Schaller S, Henriksen K, Sveigaard C et al (2004) The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 19:1144–1153PubMedCrossRef Schaller S, Henriksen K, Sveigaard C et al (2004) The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 19:1144–1153PubMedCrossRef
25.
go back to reference Henriksen K, Gram J, Hoegh-Andersen P et al (2005) Osteoclasts from patients with Autosomal Dominant Osteopetrosis type I (ADOI) caused by a T253I mutation in LRP5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol 167:1341–1348PubMed Henriksen K, Gram J, Hoegh-Andersen P et al (2005) Osteoclasts from patients with Autosomal Dominant Osteopetrosis type I (ADOI) caused by a T253I mutation in LRP5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol 167:1341–1348PubMed
26.
go back to reference Sondergaard BC, Henriksen K, Wulf H et al (2006) Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 14:738–748PubMedCrossRef Sondergaard BC, Henriksen K, Wulf H et al (2006) Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 14:738–748PubMedCrossRef
27.
go back to reference Henriksen K, Sorensen MG, Nielsen RH et al (2006) Degradation of the organic phase of bone by osteoclasts - a secondary role for lysosomal acidification. J Bone Miner Res 21:58–66PubMedCrossRef Henriksen K, Sorensen MG, Nielsen RH et al (2006) Degradation of the organic phase of bone by osteoclasts - a secondary role for lysosomal acidification. J Bone Miner Res 21:58–66PubMedCrossRef
28.
go back to reference Malone JD, Teitelbaum SL, Griffin GL et al. (1982) Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227–230PubMedCrossRef Malone JD, Teitelbaum SL, Griffin GL et al. (1982) Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92:227–230PubMedCrossRef
29.
go back to reference Martini MC, Osdoby P, Caplan AI (1982) Adhesion of osteoclasts and monocytes to developing bone. J Exp Zool 224:345–354PubMedCrossRef Martini MC, Osdoby P, Caplan AI (1982) Adhesion of osteoclasts and monocytes to developing bone. J Exp Zool 224:345–354PubMedCrossRef
30.
go back to reference Krukowski M, Kahn AJ (1982) Inductive specificity of mineralized bone matrix in ectopic osteoclast differentiation. Calcif Tissue Int 34:474–479PubMedCrossRef Krukowski M, Kahn AJ (1982) Inductive specificity of mineralized bone matrix in ectopic osteoclast differentiation. Calcif Tissue Int 34:474–479PubMedCrossRef
31.
go back to reference Hentunen TA, Cunningham NS, Vuolteenaho O et al (1994) Osteoclast recruiting activity in bone matrix. Bone Miner 25:183–198PubMedCrossRef Hentunen TA, Cunningham NS, Vuolteenaho O et al (1994) Osteoclast recruiting activity in bone matrix. Bone Miner 25:183–198PubMedCrossRef
32.
go back to reference Groessner-Schreiber B, Krukowski M, Hertweck D et al (1991) Osteoclast formation is related to bone matrix age. Calcif Tissue Int 48:335-340PubMedCrossRef Groessner-Schreiber B, Krukowski M, Hertweck D et al (1991) Osteoclast formation is related to bone matrix age. Calcif Tissue Int 48:335-340PubMedCrossRef
33.
go back to reference Groessner-Schreiber B, Krukowski M, Lyons C et al (1992) Osteoclast recruitment in response to human bone matrix is age related. Mech Ageing Dev 62:143–154PubMedCrossRef Groessner-Schreiber B, Krukowski M, Lyons C et al (1992) Osteoclast recruitment in response to human bone matrix is age related. Mech Ageing Dev 62:143–154PubMedCrossRef
34.
go back to reference Triffitt JT, Gebauer U, Ashton BA et al (1976) Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature 262:226–227PubMedCrossRef Triffitt JT, Gebauer U, Ashton BA et al (1976) Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature 262:226–227PubMedCrossRef
35.
go back to reference Melton LJ III, Khosla S, Atkinson EJ et al (1997) Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–1091PubMedCrossRef Melton LJ III, Khosla S, Atkinson EJ et al (1997) Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–1091PubMedCrossRef
36.
go back to reference Garnero P, Sornay-Rendu E Chapuy MC et al (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–349PubMedCrossRef Garnero P, Sornay-Rendu E Chapuy MC et al (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–349PubMedCrossRef
37.
go back to reference Verborgt O, Gibson GJ, Schaffler MB (2000) Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15:60–67PubMedCrossRef Verborgt O, Gibson GJ, Schaffler MB (2000) Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15:60–67PubMedCrossRef
38.
go back to reference Mullender MG, van der Meer DD, Huiskes R et al (1996) Osteocyte density changes in aging and osteoporosis. Bone 18:109–113PubMedCrossRef Mullender MG, van der Meer DD, Huiskes R et al (1996) Osteocyte density changes in aging and osteoporosis. Bone 18:109–113PubMedCrossRef
39.
go back to reference Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17:521–525PubMedCrossRef Schaffler MB, Choi K, Milgrom C (1995) Aging and matrix microdamage accumulation in human compact bone. Bone 17:521–525PubMedCrossRef
40.
go back to reference Bronckers AL, Goei W, Luo G et al (1996) DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res 11:1281–1291PubMed Bronckers AL, Goei W, Luo G et al (1996) DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res 11:1281–1291PubMed
41.
go back to reference Mori S, Burr DB (1993) Increased intracortical remodeling following fatigue damage. Bone 14:103–109PubMedCrossRef Mori S, Burr DB (1993) Increased intracortical remodeling following fatigue damage. Bone 14:103–109PubMedCrossRef
42.
go back to reference Gazit D, Zilberman Y, Turgeman G et al (1999) Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 73:379–389PubMedCrossRef Gazit D, Zilberman Y, Turgeman G et al (1999) Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 73:379–389PubMedCrossRef
43.
go back to reference Hughes DE, Dai A, Tiffee JC et al (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2:1132–1136PubMedCrossRef Hughes DE, Dai A, Tiffee JC et al (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2:1132–1136PubMedCrossRef
44.
go back to reference Ikeda T, Nagai Y, Yamaguchi A et al (1995) Age-related reduction in bone matrix protein mRNA expression in rat bone tissues: application of histomorphometry to in situ hybridization. Bone 16:17–23PubMedCrossRef Ikeda T, Nagai Y, Yamaguchi A et al (1995) Age-related reduction in bone matrix protein mRNA expression in rat bone tissues: application of histomorphometry to in situ hybridization. Bone 16:17–23PubMedCrossRef
45.
go back to reference Odetti P, Rossi S, Monacelli F et al (2005) Advanced glycation end products and bone loss during aging. Ann NY Acad Sci 1043:710–717; 2005PubMedCrossRef Odetti P, Rossi S, Monacelli F et al (2005) Advanced glycation end products and bone loss during aging. Ann NY Acad Sci 1043:710–717; 2005PubMedCrossRef
46.
go back to reference Cloos PA, Christgau S (2004) Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 5:139–158PubMedCrossRef Cloos PA, Christgau S (2004) Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 5:139–158PubMedCrossRef
47.
go back to reference Ishijima M, Rittling SR, Yamashita T et al (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399–404PubMedCrossRef Ishijima M, Rittling SR, Yamashita T et al (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399–404PubMedCrossRef
48.
go back to reference Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270PubMed Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270PubMed
Metadata
Title
Osteoclasts prefer aged bone
Authors
K. Henriksen
D. J. Leeming
I. Byrjalsen
R. H. Nielsen
M. G. Sorensen
M. H. Dziegiel
T. John Martin
C. Christiansen
P. Qvist
M. A. Karsdal
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 6/2007
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-006-0298-4

Other articles of this Issue 6/2007

Osteoporosis International 6/2007 Go to the issue